Skip to Content
Merck
CN

SML4198

Pogostone

≥98% (HPLC), powder, antimicrobial

Synonym(s):

4-Hydroxy-6-methyl-3-(4-methyl-1-oxopentyl)-2H-pyran-2-one; 4-Hydroxy-6-methyl-3-(4-methylpentanoyl)-2-pyrone, Dhelwangin

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Empirical Formula (Hill Notation):
C12H16O4
CAS Number:
Molecular Weight:
224.25
MDL number:
NACRES:
NA.21
Assay:
≥98% (HPLC)
Form:
powder
Quality level:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

SMILES string

CC(CCC(C1=C(C=C(OC1=O)C)O)=O)C

Quality Level

assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

2-8°C

Application

Pogostone may be used:
  • to study its insecticidal activity against Spodoptera litura (Fabricius) and Spodoptera exigua (Hübner)
  • to study its effects on adipose tissue inflammation in vitro and in vivo
  • to study its effects on osteolytic bone metastases in mice and investigate the molecular mechanisms of pogostone against cancer-induced osteoclast formation and cancer cell proliferation or migration in vitro

Biochem/physiol Actions

Pogostone is an active ingredient isolated from the essential oil of Pogostemon cablin (patchouli oil) that exhibits various pharmacological properties, including anti-inflammatory and anti-cancer activities. Pogostone attenuates high-fat diet–induced nonalcoholic fatty liver disease (NAFLD) in mice through inhibition of NLRP3 inflammasome signaling.

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Shengzhao Tang et al.
European journal of pharmacology, 970, 176463-176463 (2024-03-11)
Inhibition of inflammasome activation is a potential therapeutic strategy for treating nonalcoholic fatty liver disease (NAFLD). Pogostone (PO), an active ingredient in Pogostemon cablin, exhibits various pharmacological properties, including anti-inflammation. However, there are no reports of the hepatoprotective effects of
Pogostone Enhances the Antibacterial Activity of Colistin against MCR-1-Positive Bacteria by Inhibiting the Biological Function of MCR-1
Xie S, et al.
Molecules (Basel), 27 (2022)
Tao Zheng et al.
Life sciences, 328, 121611-121611 (2023-04-18)
Breast cancer is the most prevalent cancer in females, and approximately 70 % of all patients have evidence of metastatic bone disease, which substantially affects the quality of life and survival rate of breast cancer patients. Osteoporosis has become a global

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service